Articles From: Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 7106 for Treatment of Pain to Alleghany Capital Corporation Announces Investment In Jazwares


Alkermes plc (NASDAQ: ALKS) today announced the initiation of a phase 1 clinical study of ALKS 7106, a proprietary, novel, oral, small-molecule drug candidate for the treatment of pain.
Sign-up for Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 7106 for Treatment of Pain investment picks
Alkermes plc (NASDAQ: ALKS) today announced the initiation of a phase 1 clinical study of ALKS 8700, a novel monomethyl fumarate (MMF) molecule in development for the treatment of multiple sclerosis (MS). The randomized, double-blind study will evaluate the safety, tolerability and pharmacokinetics of several oral formulations of ALKS 8700 compared to both placebo and active control groups in approximately 125 healthy volunteers.
Sign-up for Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 8700 for Treatment of Multiple Sclerosis investment picks
Alkermes plc (NASDAQ: ALKS) today announced that the United States Patent and Trademark Office (USPTO) has issued Notices of Allowance for four of Alkermes’ pipeline candidates for the treatment of central nervous system (CNS) disorders: aripiprazole lauroxil, ALKS 5461, ALKS 3831 and ALKS 7106.
Sign-up for Alkermes Announces Notices of Allowance for U.S. Patents for Four CNS Pipeline Candidates investment picks
Alkermes plc (NASDAQ: ALKS) today reported financial results for the second quarter of 2014.
Sign-up for Alkermes plc Reports Second Quarter 2014 Financial Results investment picks
Alkermes plc (NASDAQ: ALKS) today announced the presentation of data from its phase 3 clinical trial of aripiprazole lauroxil, an investigational drug candidate in development for schizophrenia, at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Hollywood, Fla.
Sign-up for Alkermes Presents Phase 3 Data From Successful Pivotal Study of Aripiprazole Lauroxil for Treatment of Schizophrenia at ASCP Annual Meeting investment picks
Alkermes plc (NASDAQ: ALKS) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of aripiprazole lauroxil, the company’s investigational, novel, once-monthly, long-acting injectable atypical antipsychotic for the treatment of schizophrenia.
Sign-up for Alkermes Submits New Drug Application to FDA for Aripiprazole Lauroxil for Treatment of Schizophrenia investment picks
Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:30 a.m. EDT (1:30 p.m. BST) on Thursday, July 31, 2014, to discuss the company’s financial results for the second quarter of 2014.
Sign-up for Alkermes to Host Conference Call to Discuss Second Quarter 2014 Financial Results investment picks
Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Morgan Stanley Global Healthcare Conference on Monday, Sept.
Sign-up for Alkermes’ Corporate Presentation to be Webcast at the Morgan Stanley Global Healthcare Conference investment picks
2014/9/11
Today it was announced that Siemens has been selected to build the locomotives and passenger coaches for the All Aboard Florida passenger rail project that will connect South and Central Florida.
Sign-up for All Aboard Florida Selects Siemens as Train Manufacturer investment picks
2014/9/3
All Fund Categories Up in August, With U.S. Equities in the Lead, Morningstar Canada Data Show Canada NewsWire TORONTO , Sept.
Sign-up for All Fund Categories Up in August, With U.S. Equities in the Lead, Morningstar Canada Data Show investment picks
2014/7/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0957138001&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg http://www.ccnmatthews.com/logos/20051024-bmo_bank_logo.gif TORONTO, ONTARIO --
Sign-up for All in the Family: BMO Study Examines the Financial Mindset of Canadians With Kids investment picks
Teva Pharmaceutical Industries Ltd.
Sign-up for All Proposals Approved at Teva's Annual Meeting of Shareholders investment picks
Superior Industries International, Inc. (NYSE:SUP), the largest manufacturer of aluminum wheels for passenger cars and light-duty vehicles in North America, today announced that the three leading independent proxy advisory firms—ISS Proxy Advisory Services, Glass, Lewis & Co., and Egan-Jones—each have recommended that Superior shareholders vote the WHITE proxy card FOR all four of Superior’s director nominees at the Company’s 2014 Annual Meeting of Shareholders, to be held on August 15, 2014.
Sign-up for All Three Leading Proxy Advisory Firms - ISS, Glass, Lewis and Egan-Jones - Recommend That Superior Industries Shareholders Vote the WHITE Proxy Card FOR Superior’s Director Nominees investment picks
2014/6/18
All of the more than 250 Walgreens pharmacies and 35 Healthcare Clinic at select Walgreens throughout Ohio are now offering MMR (measles, mumps, rubella) vaccinations daily with no appointment necessary, in response to this week’s executive order from Gov.
Sign-up for All Walgreens and Healthcare Clinic Locations Across Ohio Now Offering MMR Vaccinations in Response to Executive Order investment picks
2014/8/19
Following a second straight severe flu season in the U.S., and one which impacted younger adults in particular with increased hospitalizations, health officials are encouraging early vaccination to help protect against influenza this season.
Sign-up for All Walgreens, Duane Reade Pharmacies and Healthcare Clinic at Select Walgreens Now Offering Flu Shots Daily with No Appointment Necessary investment picks
2014/8/11
Annual List Highlights 50 of the Best and Most Affordable Beauty Products Launched This Year NEW YORK , Aug.
Sign-up for ALL YOU Announces 2014 Best Beauty Buys Winners investment picks
Industry-leading suite of services now called Charter Spectrum IRWINDALE, Calif.
Sign-up for All-Digital Network Brings Faster Internet Speeds, More HD Channels for Charter Customers in Southern California investment picks
2014/8/14
The all-new Ford Transit will help the King family complete farm chores on season four of the Great American Country Network’s lifestyle series “Farm Kings,” which premieres Friday, Aug.
Sign-up for All-New 2015 Ford Transit Goes to Work on Great American Country Network’s ‘Farm Kings’ investment picks
2014/7/29
In developing the all-new 2015 MKC small premium utility, The Lincoln Motor Company strived to create a vehicle that displayed the company’s commitment to quality and craftsmanship.
Sign-up for All-New Deepsoft Leather Allows Lincoln to Bridge Past and Present with MKC investment picks
2014/6/24
Ford Edge is about to expand its global footprint in a big way.
Sign-up for All-New Ford Edge Courts More Global Customers with More Driver-Assist Technologies, Improved Performance, Design investment picks
2014/7/22
With its new 2.7-liter EcoBoost ® with standard Auto Start-Stop and new 3.5-liter V6 with twin independent variable camshaft timing, the 2015 Ford F-150 resets the bar in light-duty pickup truck performance, capability and efficiency.
Sign-up for All-New Ford F-150 2.7-Liter EcoBoost V6 Engine Delivers V8 Capability and Performance investment picks
LAWRENCE, Mass.
Sign-up for Allan J. Collins, M.D., to join NxStage as Senior Medical Advisor investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0962144001&sourceType=1 http://www.ccnmatthews.com/logos/20100122-allana200.jpg TORONTO, ONTARIO --
Sign-up for Allana Potash Engages AMEC to Complete Front End Engineering and Design Studies on Danakhil Project investment picks
2014/7/30
Allbanc Split Corp.
Sign-up for Allbanc Split Corp. II Declares Quarterly Dividends investment picks
IRVINE, Calif., Aug.
Sign-up for AllDigital Holdings, Inc. Announces Passing of CEO Paul Summers investment picks
2014/9/2
NEW YORK , Sept.
Sign-up for Alleghany Announces Commencement Of Senior Notes Public Offering investment picks
2014/9/2
NEW YORK , Sept.
Sign-up for Alleghany Announces Pricing Of $300 Million Of 4.900% Senior Notes Due 2044 investment picks
2014/8/4
NEW YORK , Aug.
Sign-up for Alleghany Capital Corporation Announces Investment In Jazwares investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 7106 for Treatment of Pain to Alleghany Capital Corporation Announces Investment In Jazwares
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices